Search Results - "Zylberman, I"

Amelioration of negative symptoms in schizophrenia by glycine by Javitt, D C, Zylberman, I, Zukin, S R, Heresco-Levy, U, Lindenmayer, J P

“…Phencyclidine induces a psychotomimetic state by blocking neurotransmission at N-methyl-D-aspartic acid (NMDA) receptors. In a double-blind, placebo-controlled…”
Get more information

Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study by Javitt, D C, Doneshka, P, Zylberman, I, Ritter, W, Vaughan, Jr, H G

“…Abnormalities of auditory information processing represent a core feature of schizophrenic psychopathology. Event-related potentials (ERP) provide an objective…”
Get more information

Tic-like syndrome after treatment with clozapine by Lindenmayer, J P, Da Silva, D, Buendia, A, Zylberman, I, Vital-Herne, M

Get more information

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial by Leiderman, Eduardo, Zylberman, Ilana, Zukin, Stephen R., Cooper, Thomas B., Javitt, Daniel C.

Get full text

NMDA receptor augmentation therapy in schizophrenia by Zylberman, I., Javitt, D.C., Zukin, S.R.

Get full text

Pharmacological augmentation of NMDA receptor function for treatment of schizophrenia by Zylberman, I, Javitt, D C, Zukin, S R

Get more information

Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists by Nussenzveig, I Z, Sircar, R, Wong, M L, Frusciante, M J, Javitt, D C, Zukin, S R

“…Polyamines such as spermidine potentiate activation of the N-methyl-D-aspartate (NMDA)-type excitatory amino acid receptor. The goal of the present study was…”
Get more information